Julie FarrJulie has over thirty years’ international finance experience across the US, Europe and Asia-Pacific, working with both private and listed companies. As Group Finance Controller for cancer diagnostics company VolitionRx, Julie worked with the C-Suite to up-list onto NYSE American and to raise multiple rounds of capital. She has worked with management teams within the biotech and technology sectors to raise both private financing and public capital, and has also led financial due diligence through M&A activities. Julie has a BA (hons) from the University of Cambridge in Management Studies with a Natural Sciences background. She qualified as a Chartered Accountant with BDO.